The National Institutes of Health (NIH) is facing a power struggle over institute directorships, with the Trump administration seeking to exert more control over key leadership positions. The agency has traditionally relied on a process that involves search committees consisting of both NIH career scientists and external experts, but sources close to the agency say this practice is being abandoned in favor of a compressed timeline and fewer external members.
The changes come as some senior officials at NIH were put on administrative leave or abruptly departed after Trump's inauguration, including Lawrence Tabak, who had spent more than a decade as principal deputy director. The administration has also grown the number of political appointees at the agency, with nine current holdovers as of late June, up from four the year before.
Five institute directors, including the head of NIAID, were fired or placed on administrative leave in the spring of 2025, and their positions have since been removed. The directorship of another agency, the National Institute of Environmental Health Sciences, was filled by a close personal friend of Vice President JD Vance without any apparent search process.
The move has prompted speculation among NIH insiders that the Trump administration is seeking to exert more political control over the hiring of directorships, and some lawmakers are taking notice. A bill sponsored by Diana DeGette, a Democratic representative from Colorado, aims to "Protect NIH From Political Interference" by capping the number of political appointees at the agency.
Critics argue that the changes undermine the traditional process for selecting institute directors, which has been successful in bringing fresh ideas and perspectives to the agency. Mark Histed, an NIH scientist, said that external members on search committees are crucial for preventing politicization and ensuring that the agency remains responsive to the scientific community.
The NIH's role in biomedical research is significant, and any changes to its leadership structure could have far-reaching consequences. The agency has historically enjoyed strong bipartisan support, but conservative lawmakers have periodically raised questions about some of its spending and perceived liberal leanings. The Trump administration's actions may be seen as an attempt to exert more control over the agency and shape its research agenda in line with Republican priorities.
As the power struggle over institute directorships at NIH continues, it remains to be seen whether the agency will be able to maintain its independence and continue to deliver high-quality research and services to the public.
The changes come as some senior officials at NIH were put on administrative leave or abruptly departed after Trump's inauguration, including Lawrence Tabak, who had spent more than a decade as principal deputy director. The administration has also grown the number of political appointees at the agency, with nine current holdovers as of late June, up from four the year before.
Five institute directors, including the head of NIAID, were fired or placed on administrative leave in the spring of 2025, and their positions have since been removed. The directorship of another agency, the National Institute of Environmental Health Sciences, was filled by a close personal friend of Vice President JD Vance without any apparent search process.
The move has prompted speculation among NIH insiders that the Trump administration is seeking to exert more political control over the hiring of directorships, and some lawmakers are taking notice. A bill sponsored by Diana DeGette, a Democratic representative from Colorado, aims to "Protect NIH From Political Interference" by capping the number of political appointees at the agency.
Critics argue that the changes undermine the traditional process for selecting institute directors, which has been successful in bringing fresh ideas and perspectives to the agency. Mark Histed, an NIH scientist, said that external members on search committees are crucial for preventing politicization and ensuring that the agency remains responsive to the scientific community.
The NIH's role in biomedical research is significant, and any changes to its leadership structure could have far-reaching consequences. The agency has historically enjoyed strong bipartisan support, but conservative lawmakers have periodically raised questions about some of its spending and perceived liberal leanings. The Trump administration's actions may be seen as an attempt to exert more control over the agency and shape its research agenda in line with Republican priorities.
As the power struggle over institute directorships at NIH continues, it remains to be seen whether the agency will be able to maintain its independence and continue to deliver high-quality research and services to the public.